Swiss Company Raises €23M to Smash Cancer with Bacteria
Basel-based T3 Pharmaceuticals has closed its third financing round, worth over €23.3M (CHF 25M), to…
24/07/2020 - 2 minutes
Trends & News
Pharma Giant GSK and mRNA Biotech CureVac Ink €1B Deal
GlaxoSmithKline (GSK) has struck a deal worth up to €1B with the German biotechnology company…
23/07/2020 - 3 minutes
Inhaled Treatment Reduces Severe Covid-19 Risk by 79%
An experimental Covid-19 treatment that is delivered directly to the lungs via a nebulizer reduced…
22/07/2020 - 3 minutes
Global €870M Fund Launched to Address Antimicrobial Resistance
A global collaboration including the pharmaceutical industry and public funders such as the European Investment…
21/07/2020 - 3 minutes
Russian Hackers Launch Cyber Attack on Covid-19 Vaccine Developers
The National Cyber Security Centre (NCSC) in the UK stated this week that several organizations…
17/07/2020 - 3 minutes
Two UK Startups Raise Seed Funding to Revolutionize Cancer Treatment
Unfazed by the financial turmoil caused by the Covid-19 pandemic, the Edinburgh-based firm Macomics and…
17/07/2020 - 3 minutes
Danish Wound Healing Biotech Raises €20M to Accelerate US Rollout
Reapplix, a Danish biotech focusing on developing wound healing technology, has raised €19.8M in equity…
17/07/2020 - 3 minutes
European Biotech Stocks Shine Amid 2020 Market Slump
As the Covid-19 pandemic leads us to the worst financial crisis in decades, normally volatile…
16/07/2020 - 4 minutes
Amryt Makes Nasdaq Debut to Fund Rare Disease Treatments
UK-based biopharmaceutical Amryt Pharma has listed on the Nasdaq Stock Market in a move to…
14/07/2020 - 3 minutes
€32M Series B to Fund Bleeding Medication Inspired by Snake Venom
The Dutch biotech VarmX will use the proceedings of a €32M Series B to take…
14/07/2020 - 2 minutes
Sanofi Enlists Cell Therapy Firm Kiadis in €875M Immuno-Oncology Deal
The Dutch biotech Kiadis Pharma has licensed an off-the-shelf cell therapy program to the pharma…
13/07/2020 - 3 minutes
Forbion Raises €185M to Fuel Late-Stage European Biotechs
The Dutch life sciences venture capital firm Forbion has bagged €185M in the first closing…
13/07/2020 - 3 minutes
